Abstract
To evaluate the efficacy of primary prophylaxis for Pneumocystis jiroveci pneumonia (PCP) in patients with connective tissue disease (CTD) and immunosuppression, we compared trimethoprim–sulfamethoxazole (TMP-SMZ) with aerosolized pentamidine. Forty-eight CTD patients of Kitasato University Hospital whose CD4+ lymphocyte count in the peripheral blood was less than 300 μl−1 were reviewed from 2002 to 2004. Twenty-seven patients received TMP–SMZ and none of them developed PCP. Among 18 patients receiving aerosolized pentamidine, three patients developed PCP. These data indicate that TMP–SMZ is better for prophylaxis than aerosolized pentamidine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, Frame PT, Holmes M, Waskin H, Fass RJ (1992) A controlled trial of trimethoprim–sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med 327:1842–1848
Schneider MM, Hoepelman AI, Eeftinck Schattenkerk JK, Nielsen TL, van der Graaf Y, Frissen JP, van der Ende IM, Kolsters AF, Borleffs JC (1992) A controlled trial of aerosolized pentamidine or trimethoprim–sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. N Engl J Med 327:1836–1841
Sato T, Inokuma S, Maezawa R, Nakayama H, Hamasaki K, Miwa Y, Okazaki Y, Yamashita M, Tanaka Y, Kono H (2005) Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseases. Mod Rheumatol 15:191–7
Li J, Huang XM, Fang WG, Zeng XJ (2006) Pneumocystis carinii pneumonia in patients with connective tissue disease. J Clin Rheumatol 12:114–117
Ward MM, Donald F (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 42:780–789
Okada J, Kadoya A, Rana M, Ishikawa A, Iikuni Y, Kondo H (1999) Efficacy of sulfamethoxazole–trimethoprim administration in the prevention of Pneumocystis carinii pneumonia in patients with connective tissue disease. Kansenshogaku Zasshi 73:1123–1129
Yasuoka A, Tachikawa N, Shimada K, Kimura S, Oka S (1996) (1→3) β-d-Glucan as a quantative serological marker for Pneumocystis carinii pneumonia. Clin Diagn Lab 3:197–199
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kimura, M., Tanaka, S., Ishikawa, A. et al. Comparison of trimethoprim–sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease. Rheumatol Int 28, 673–676 (2008). https://doi.org/10.1007/s00296-007-0505-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-007-0505-4